AstraZeneca banks on MasterCard for director
March 20, 2014Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Johansson, ann cairns, british gas, mastercard
AstraZeneca is proposing to elect the president of International Markets for MasterCard to stand as a non-executive director on its …
AstraZeneca signs Vodafone contract
March 20, 2014Medical Communications, Sales and Marketing AstraZeneca, cardiovascular, mhealth, vodaphone
AstraZeneca has signed up with phone operator Vodafone to provide mobile health (mHealth) services for patients suffering from cardiovascular issues. …
GSK cancer vaccine fails again
March 20, 2014Sales and Marketing Cancer, GSK, MAGE-A3 cancer immunotherapeutic, NSCLC, lung cancer, melanoma
GlaxoSmithKline’s MAGE-A3 cancer immunotherapeutic has delivered another late-stage blow to the firm but it still vows to continue trials. The …
BIA welcomes budget statement
March 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Budget, Osborne, R&D, seed, sme
An increase in R&D tax credits and the creation of a cell therapy manufacturing centre were two of the highlights …
Takeda hires head of emerging markets
March 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, giles platford
Giles Platford has been appointed head of commercial operations, emerging markets for Swiss-based pharma firm Takeda. Reporting to its chief …
FDA ‘not trusted’ by Americans
March 19, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, JAMA, MMR, US, america, conspiracy, yougov
More than one-third of Americans in a new survey think the Food and Drug Administration is holding back new cures …
Allergan reprimanded over Botox promotion
March 19, 2014Medical Communications, Sales and Marketing ABPI, Allergan, Botox, Galderma, PMCPA, vistabel
Allergan has been found guilty of breaching six clauses of the ABPI’s Code of Practice over its market research for …
Merck Serono appoints head of strategy from Roche
March 19, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Meeta Gulyani, Merck Serono, Roche
Merck Serono the German biopharma division of Merck has appointed Meeta Gulyani to the position of head of strategy and …
Europe: TB treatment ‘far below’ target
March 19, 2014Research and Development, Sales and Marketing EU, MDR TB, TB, WHO, tuberculosis
European countries are still not getting to grips with the diagnosis and treatment of tuberculosis, according to a new report …
Success for Amgen’s ‘bad’ cholesterol injection
March 18, 2014Research and Development, Sales and Marketing Amgen, LDL, PCSK9, evolocumab, hofh, tesla
An investigational PCSK9 Inhibitor from Amgen has reduced LDL-C (‘bad’ cholesterol) in patients suffering from a rare genetic disorder in …
BMS hopes for Yervoy sequel with new deal
March 18, 2014Research and Development, Sales and Marketing Avapro, BMS, Plavix, Yervoy, five prime, immune-oncology
Bristol-Myers Squibb has announced a new research and development deal with Five Prime Therapeutics aimed at discovering potentially new cancer …
Pfizer sues over Viagra generic
March 18, 2014Sales and Marketing ED, FDA, Pfizer, Sildenafil, torrent, viagra
Pfizer is suing Torrent Pharmaceuticals in order to stop it selling copycat versions on its big-selling erectile-dysfunction drug Viagra. The …
Patheon completes $2.65 billion merger with DSM
March 18, 2014Manufacturing and Production, Sales and Marketing CDMO, DSM, Patheon, dpx, manufacturing
The $2.65 billion merger between Patheon and DSM’s pharma business has completed, creating a new privately-held company called DPx. The …
IDEA Pharma appoints vice president
March 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IDEA Pharma, Jacquelyn Nicholson
Biopharma firm IDEA Pharma has appointed Jacquelyn Nicholson as vice president to head up its west coast US operations. Nicholson …
Pharma manufacturing news in brief
March 18, 2014Manufacturing and Production Aesica, Alvotech, Codexis/Intrexon, Pluristem, Updates from Bayer
Bayer says it plans to invest more than €500 million to establish additional manufacturing capacity for its haemophilia drugs at …
Sun Pharma comes under FDA import alert
March 17, 2014Manufacturing and Production Sun Pharma, diabetes, gabapentin, manufacturing, metformin, recall
The reputation of India’s pharma sector has been dealt a further blow after yet another drugmaker was placed under an …
Novo Nordisk unveils plans for $100m API plant
March 17, 2014Manufacturing and Production API, FDA, Novo Nordisk, Taylor, copenhagen
Novo Nordisk says it will invest around $100m in a new pilot facility to make the active pharmaceutical ingredients (APIs) …
Boehringer’s first cancer drug gains NICE yes
March 17, 2014Sales and Marketing Boehringer, Cancer, NICE, NSCLC, afatinib, giotrif
NICE is recommending that Boehringer Ingelheim’s first oncology treatment Giotrif be funded by the NHS. The new final draft guidance …
Amgen melanoma vaccine shrinks tumours
March 17, 2014Research and Development, Sales and Marketing Amgen, Cancer, Yervoy, melanoma, t-vec
Amgen’s investigational cancer vaccine T-vec has managed to shrink the size of advanced melanoma tumours in a late-stage trial. The …
Major new launches for 2014
March 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AZ, AbbVie, Big Pharma, Merck, Novartis, Pfizer, Roche, Sanofi, ask, johnson, lilly, top 10
AbbVie AbbVie needs a blockbuster to eventually replace its flagship Humira – and is hoping its new hepatitis C treatments …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
